Purpose. First-degree relatives (FDRs) of prostate cancer (PC) patients should consider multiple concurrent personal risk factors when engaging in informed decision making (IDM) about PC screening. This study assessed perceptions of IDM recommendations and risk-appropriate strategies for IDM among FDRs of varied race/ethnicity. Design. A cross-sectional, qualitative study design was used. Setting. Study setting was a cancer center in southwest Florida.
PURPOSE
Prostate cancer (PC) is the most commonly diagnosed cancer aside from skin cancer and the second leading cause of cancer deaths among American men. An estimated 233,000 men will be diagnosed with PC, and approximately 29,480 men will die from the disease in 2014. 1 The strongest risk factors for PC are family history, older age, and African ancestry. 1 Incidence and mortality are both higher for black men compared with their white counterparts. 1 This disproportionate impact is even more pronounced when black men are compared with other racial/ethnic minority groups, such as Asian, Hispanic/Latino, and American Indian/ Alaska Native men. 1 Unaffected men with a family history of PC have a higher risk of being diagnosed with PC compared with men without a family history. 2 PC risk doubles for firstdegree relatives (FDRs), specifically the biologic siblings, sons, or parents of men with PC, and risk increases threefold when more than one FDR has PC. 2 PC risk is greater for sons compared with brothers of a PC patient, and for younger siblings (vs. older siblings). [2] [3] [4] Screening tests for PC are widely available and include the digital rectal exam and the prostate-specific antigen (PSA) test. However, routine screening for PC remains highly debated regarding the value and benefits of screening for asymptomatic men, including FDRs. 5, 6 Two landmark studies reported contradictory findings about the benefits of routine PC screening. A European study found limited evidence of survival benefits of annual PSA testing and treatment. 5 The results of the U.S.-based Prostate Lung Colorectal Ovarian Cancer trial did not provide support for the benefits of PC screening; specifically, PC mortality rates did not differ between annual screening and usual care. 6 Therefore, arguments persist that widespread screening will lead to significant increased diagnosis of indolent disease (overdiagnosis) that may not cause harm (morbidity, such as symptoms; or mortality). In addition, finding indolent disease may result in unnecessary treatment and morbidity due to treatment complications. 7, 8 Treatments for early-stage, localized PC include surgery (prostatectomy), external beam radiation therapy, prostate seed implant (brachytherapy), or combinations of these modalities with or without hormone therapy. 9 Common complications of various treatment modalities include urinary incontinence and other bladder control problems, sexual impotence or erectile dysfunction, and rectal complications, such as chronic diarrhea. 9 Subsequently, the U.S. Preventive Services Task Force revised its 2008 PC screening recommendation from ''insufficient evidence'' to a definitive recommendation against routine screening. 10 Recently, leading health policy organizations, such as the American Cancer Society and American Urological Association, have also changed their policies and no longer recommend routine PC screening. 1, 7 All leading health policy organizations now recommend that men, including those at highest risk, should be provided with information that discusses both the potential benefits and harms of routine PC screening in order to facilitate individual informed decisions about whether or not to undergo testing based on personal values and preferences. 1, 7, 10 However, contrary to policy organization recommendations, PC screening in primary care and community settings remains a routine practice. [11] [12] [13] Given their higher risk status, men with a family history and other concurrent risk factors are faced with difficult decisions about routine screening for PC. 5 This presents a dilemma impinging on the prevailing paradigm regarding informed decision making (IDM) against the practice of routine screening. Thus, research aimed at helping men with screening decisions (for or against) remains vitally important. 14 There is growing evidence that patient decision aids are helpful in preparing men to make a decision about whether or not to be tested. [15] [16] [17] [18] [19] [20] [21] Desirable outcomes of decision aids include increased awareness and knowledge of PC and screening, reduced uncertainty or decisional conflict about screening decisions, and satisfaction with screening decisions made. 2, 16, 22 Decisional conflict is often characterized by personal uncertainty in choosing a definitive course of action (e.g., whether to be screened or not) among competing actions that involve risks and benefits, potential for regret, and possible challenges to personal values and preferences. 23 Decisional conflict may stem from inadequate knowledge, unclear values due to controversy, or dissatisfaction with decision or choice made (i.e., the feeling that an ineffective decision has been made). Patients who experience decisional conflict may seek more information to clarify, or may avoid making a decision altogether and simply maintain the status quo. Men who have decisional conflict may worry more about what to do regarding PC screening, or worry whether the decision they made is the right one for them. 16, 19 For example, because of their increased risk associated with family history and African ancestry, black FDRs may be more conflicted on whether or not to do routine asymptomatic screening.
Few studies have adequately examined the perspectives and preferences of men at increased risk due to family history or family history combined with African ancestry. Men with multiple risk factors were no more likely to screen than men with only one risk factor. 2 FDRs, who have the strongest risk compared with average-risk populations, must consider multiple concurrent personal risk factors (e.g., age, race/ethnicity, and family history) when engaging in structured PC screening IDM. Because black race/ ethnicity is a risk factor for PC, the Centers for Disease Control and Prevention (CDC) developed a separate decision aid for African-Americans. Tailoring by race/ethnicity is thought to have a higher positive impact on behavior by incorporating surface-and deep-structure cultural and social contexts into the decision aid. [24] [25] [26] However, there is a need to assess various strategies for addressing and incorporating culture into decision aids, 25 particularly for PC screening decision aids.
To our knowledge, no decision aid has been developed in the United States specifically for FDRs of PC patients (i.e., brothers and sons). Given this paucity of decision aids developed for and tested with FDRs, this study sought to qualitatively assess PC patients' and unaffected FDRs' understanding of the PC screening controversy, perceptions of IDM recommendations, and risk-appropriate strategies for IDM among FDRs. A secondary objective was to assess whether patients and FDRs preferred a separate decision aid for black FDRs (given the increased PC risk for this group). Ultimately, the information gained would help identify the salient elements and specific messages to be included in a decision aid targeted specifically toward FDRs.
METHODS

Design
This paper reports qualitative data from the first part of a larger pilot study. The design of the larger pilot study included two phases involving: (1) formative qualitative methods (focus groups and individual interviews) to develop a decision aid with increased relevance to FDRs, and (2) For individual use only. Duplication or distribution prohibited by law.
quantitative randomized pilot study to evaluate the targeted decision aid using a two-arm comparative design. Data analysis for the randomized pilot study is still in progress. The study received University of South Florida institutional review board approval. All participants provided written informed consent before participation.
Setting
This study was conducted at a National Cancer Institute-designated comprehensive cancer center in southwest Florida. PC patients were recruited from the clinical databases of the cancer center and support groups in the community, and they nominated their FDRs.
Participants
The formative qualitative phase included both PC patients and unaffected FDRs (regardless of PC screening status) to achieve a broad representation of perspectives on the barriers, harms, and benefits of screening. PC patients were recruited because they are critical in discussions of PC screening, diagnosis, and treatment experience with their FDRs, and hence could be an important partner in dissemination of the decision aids to their FDRs.
To be invited to participate in the study, eligible PC patients had to: (1) self-identify as non-Hispanic black or non-Hispanic white; (2) have completed definitive PC treatment; (3) reside in the tricounty Tampa Bay area (Hillsborough, Pinellas, and Pasco counties, Florida); (4) agree to attend a focus group; (5) speak, read, and write in English; and (6) provide written informed consent. PC patients were asked to nominate at least one male FDR (son or brother) with no personal history of PC. Eligible FDRs had to: (1) self-identify as a non-Hispanic black or non-Hispanic white male between the ages of 40 and 70 years; (2) report no personal history of any cancer, excluding nonmelanoma skin cancer; (3) speak, read, and write in English; (4) agree to participate in an individual telephone interview; and (5) provide written informed consent.
PC patients were identified via clinical databases, approached in waiting rooms, or approached while attending community support groups. Patients nominated potentially eligible FDRs using a well-documented methodology 27, 28 where PC patients were contacted by mail or telephone and requested to nominate their male FDRs and provide contact information to researchers. The researchers then contacted FDRs by telephone or mailed a letter introducing them to the study and asking them to call the study team if interested or to decline participation in the study. Individuals who expressed interest in participating were contacted by telephone to evaluate eligibility. Eligible FDRs were mailed a consent form and asked to sign and return the consent form by mail.
Data Collection
Four focus groups (patients only) were held at either the cancer center or in community locations, such as public libraries, in southwest Florida. The focus group and interview guides were developed based on key research questions and with input from our cultural advisors (two black males and one white male)-all of whom were PC patients. The cultural advisors added their perspectives for recruitment, and they brought rich experiences about family communication about disease experience and sharing diagnosis, screening decisions, and treatment decisions and outcomes. The advisors provided feedback on the CDC decision guides and focus group and interview guides, reviewed aggregated participant data, reviewed scripts for DVD development, and appeared in the resulting DVD. Two experienced male researchers (black and white) trained in qualitative research methods comoderated the focus groups. The moderators were matched by race of the focus group participants. That is, the white researcher was the lead moderator of the focus groups for white patients, whereas the black researcher was the lead moderator of the focus groups for black patients. Comoderators audiorecorded each focus group and took handwritten notes.
Focus groups were separated by race, consisted of at least 5 participants, and lasted about 90 minutes. During each session, PC patients provided their views about PC screening, IDM processes, and the content of information they believed should be communicated to FDRs. Patients were mailed and asked to review and compare the two existing CDC decision guides (brochures) before attending the focus group: the general population brochure ''Prostate Cancer Screening: A decision guide,'' and a race-targeted brochure entitled ''Prostate Cancer Screening: A decision guide for African-Americans.'' 29, 30 PC patients were asked to provide specific feedback on the strengths and limitations of each section of the CDC decision guides with regard to potential use with their FDRs. We used the concept of thematic saturation-where saturation is the point when no new information or themes emerge-to determine how many focus groups were enough. 31, 32 Because of the geographic distribution of FDRs, using focus groups for FDRs was not feasible. Instead, all FDRs were interviewed individually via the telephone. Telephone interviews lasted on average 30 minutes. The interview included assessment of the FDRs' current perceptions of their information needs and outcomes of screening IDM, including how they feel about screening, how they weigh pros and cons, and what facts they felt they needed to make a decision. FDRs were also mailed both of the CDC decision guides, and were asked for their reactions to the existing content during their interview. In accordance with the literature suggesting that 6 to 12 interviews are enough to reach thematic saturation, 33 we sought to accrue 20 FDRs (10 in each racial category).
PC patient focus groups were separated by race to assess whether there was a need to develop two separate versions of the targeted decision aid (DVDs), consistent with the available versions of the CDC screening decision guides. 29, 30 A similar question about the need for a separate decision aid was asked in each FDR interview.
Analysis Strategies
All focus groups and interviews were audiotaped and transcribed verbatim by a professional transcriptionist. Data were analyzed using a combination of content analysis (of transcripts and handwritten notes) and the constant comparison methods. 34, 35 A priori and emergent codes were used to develop the study codebook. The a priori codes For individual use only. Duplication or distribution prohibited by law.
were derived from the study research questions, and emergent codes were added to the codebook as data analysis progressed. Four investigators within the study team, including the lead author, formed two paired teams for transcript coding. Each transcript was individually coded by a paired team of investigators, and the coding results were compared within the team to ensure reliability (dependability). AT-LAS.ti (version 5.2; Atlas ti GmbH, Berlin, Germany) was used to manage and analyze the text from transcripts. The analyzed data and emergent themes were discussed with the research team and cultural advisors to ensure appropriate interpretation and consensus of the results. Data were analyzed separately for FDRs vs. PC patients, with race (black vs. white) as a secondary stratification for both groups.
RESULTS
Participant Characteristics
A total of 44 men (24 PC patients and 20 FDRs) participated in this study.
Characteristics of participants are summarized in Table 1 . Four focus groups were conducted (two focus groups per racial group) with a total of 24 PC patients (14 black patients; 10 white patients). The median age was 63 years (range, 46-82 years). PC patients were within 5 years of completing definitive therapy with either prostatectomy (50%) or radiation therapy (50%). A total of 20 unaffected FDRs (9 black FDRs; 11 white FDRs) completed individual telephone interviews. The median age of FDRs was 59.4 years (range, 41-69 years). A total of 17 FDRs (85%) had previously been screened for PC (any test), whereas 3 (15%) had never been screened. Among FDRs, 30% had a father who had PC, 55% had a brother who had PC, and 15% had both a father and brother who had PC.
Qualitative Findings
We sought to discover how PC patients and their FDRs perceive the PC screening controversy and IDM recommendations, in order to identify salient elements to be included in a decision aid targeted specifically toward FDRs. Focus groups and individual interviews helped to identify new content topics as well as clarify men's preferences for information and desired level of participation in IDM. Table 2 summarizes selected findings in four key areas that directly informed development of the targeted decision aid for FDRs, including: (1) patients' and FDRs' perceptions of PC screening controversy and IDM; (2) perceived lack of disclosure or discussion of PC diagnosis; (3) FDRs' fear and avoidance of the topic of PC screening; and (4) FDRs' receptivity to social influence by their affected relatives. There were no prominent differences by race/ethnicity across the targeted key areas, suggesting common perceptions for both racial groups. Therefore, pooled results for both races among patients and FDRs are summarized by theme in the upcoming text.
Patients' and FDRs' Perceptions of PC Screening Controversy and IDM. Patients and FDRs found the PC screening debate and IDM recommendations to be complex and counterintuitive. There was strong resistance to IDM messages, with most participants in favor of promoting screening. They asserted that because PC was so common and could be detected early (through routine PSA and digital rectal exam screening), the screening debate and the IDM recommendation/paradigm did not make sense to them. Both patients and FDRs did not see apparent harms or risks associated with screening; hence, they placed a high importance on promoting screening instead of IDM, especially for a higherrisk group, such as FDRs. These sentiments are embodied in these representative quotes.
''I mean, I think there's just too much confusion going on with this and that. . . it's lacking focus on. . .on the positive aspects of being checked.'' (patient) ''. . .I don't understand the controversy of why all of a sudden it's being brought up that doctors. . .don't agree with the test. . .that's how I was diagnosed. . .'' (patient) ''. . .I don't see any down sides to being screened, it's not invasive, it's For individual use only. Duplication or distribution prohibited by law. Although patients and FDRs felt the CDC decision guides could stimulate discussions among patients, FDRs, and health care providers, they found the CDC decision guides to be complex and vague in their explanation of the controversy and call to action. Both groups, regardless of racial background, specifically preferred a clear, targeted message for FDRs urging them to ''get screened'' because of their higher risk of developing the disease. ''I think that we all have a responsibility to talk to our brothers and our sons about it.'' (patient) ''I think we as men don't share that much information between us, until my dad died of cancer. . .it was ten years before we found out. . .he kept [it] hidden from us.'' (FDR)
FDRs' Fear and Avoidance of PC Screening. Patients and FDRs concurred on their perceptions that there is widespread fear and avoidance of discussing PC screening among FDRs. This fear emanates from the anticipated impact of PC diagnosis and treatment on sexual performance; hence, many FDRs tend to avoid discussing the topic of PC or screening. Role of PC Patients in PC IDM. An emergent key finding was that FDRs are receptive to advice of their affected family member and find patients to be credible influences with regard to communications about PC and PC screening. Similarly, most patients were highly motivated to ''protect'' their FDRs through information sharing and education. These dynamics can be gleaned from the FDR sentiments shown here.
''The survivors have the best opportunity to say I'm here today because I got tested.'' (FDR) ''I think that the most credible information you have is when you get it from a brother [survivor]. . . whose opinion you value.'' (FDR) Is a Separate Decision Aid Needed for the Black Population? Both patients and FDRs (black and white) advocated for a single decision aid that highlights the importance of family history and the increased risk for the black population. Black participants in particular strongly supported a common decision aid stating that all of the important differences could be covered and still appeal to both groups. For example, the decision aid could provide disease statistics that highlight racial/ethnic differences as needed, could feature comments from both white and black individuals, and could draw on similarities about understandings/misunderstandings to enhance clear communication. Their sentiments are embodied in the following statements. These findings informed and guided our decision to develop one common decision aid for both racial/ethnic groups. There was also overwhelming support to develop a DVD rather than a paper-based decision aid or any other type of electronic or social media. There was overwhelming support for this format by cultural advisors and participants to ensure the information is accessible to all strata of the population. In addition, the DVD content could be adapted easily in the future to accommodate other media formats, such as mobile apps and Web sites, thus widely disseminating the message and extending its utility.
Infusion of Qualitative Findings in an FDR-Targeted Decision Aid
The findings from the focus groups and interviews informed the content of the targeted decision aid (DVD). Space limitations preclude full discussion of the DVD development process. In short, the decision aid was constructed to promote skills and confidence for FDRs to engage in IDM and discuss PC screening with health care providers. 36, 37 The content, tone, and format of the decision aid were structured to address opportunities, concerns, and barriers to IDM identified in formative work. For individual use only. Duplication or distribution prohibited by law.
tured in the DVD (vs. professional actors), thus increasing the likelihood that the audience could readily identify with the messengers and their IDM message. Key sections of the resulting DVD titled ''Deciding about PC screening: A family matter'' were:
discussion and deconstruction of the PC screening debate to improve understanding of the controversy and arguments for or against routine screening; and step-by-step guidance for patients and FDRs on how to speak to their family members and their health care providers about PC in order to facilitate IDM about screening. These critical strategies were reinforced by statistics, and the testimony of physicians, patients, FDRs, and the narrator in the video.
A four-step approach to IDM represented by a 4-D mnemonic was also included. The 4-Ds include: (1) Data: gather as much information to facilitate discussions with your health care provider; (2) Discuss: talk to your health care provider and family members; (3) Deliberate: consider both the benefits and harm of routine screening; and (4) Decide: make a decision that is right for you.
Once a draft DVD was produced, learner verification was conducted with patients (n ¼ 3) and FDRs (n ¼ 9) who had not participated in formative interviews/focus groups, in order to assess the suitability of the new decision aid in terms of acceptability, attractiveness, understandability, persuasion, and self-efficacy. 38 All participants involved in the learner verification of the decision aid found the length and information appropriate, and easy to understand, and found that it simplified the screening controversy, simplified the potential harm and benefits of screening, and provided a clear step-by-step process for initiating discussions with health care providers and making an informed decision. All found the DVD to be a highly acceptable learning format.
CONCLUSION
Findings in this mixed qualitative methods study of PC patients and unaffected FDRs underscore the complexity of the PC screening controversy and challenges in implementing the consensus recommendation to promote IDM among a population at increased risk. Several barriers and opportunities to improve PC screening education and IDM were identified in this study. The barriers to IDM included lack of awareness and misunderstanding of PC screening debate and IDM, lack of communication between patients and their FDRs, FDRs' fear and avoidance of PC as a topic, lack of a step-by-step guide to simplify the IDM process, and limited strategies to help FDRs speak to health care providers about screening and IDM. On the other hand, findings suggest receptivity to a decision aid that helps patients share their experience and help their FDRs.
Our findings highlight several challenges in the prevailing paradigm of PC screening IDM and the recently revised position against routine PC screening by many leading health policy organizations. Many patients and FDRs found the IDM recommendations to be counterintuitive. It is clear that patients in this study are potentially biased toward a proscreening message. This is demonstrated by patients' strong preference for involvement in the process of preparing their own unaffected FDRs in directed PC screening to improve early detection. Patients urged other survivors to take an active role in discussing their family history of this disease and to educate their own male siblings and sons for the sole purpose of improving early detection of PC. When a patient's proscreening position is juxtaposed against a health policy recommendation in favor of IDM, challenges for achieving education and IDM in community settings are inherent. It remains to be seen whether patients can indeed operationally adhere to a balanced discussion of the pros and cons of PC screening per guidelines. For some men, the benefits of PC screening were a ''no brainer,'' and the risks were obscure or nonexistent. The pragmatic role of patients as partners with the health care providers in efforts to promote (balanced) IDM among their own FDRs remains unclear and requires further research.
These challenges notwithstanding, our findings on the perspectives of both patients and FDRs were insightful and directly instrumental in the development of a targeted decision aid for PC screening for FDRs. The ''takehome message'' is two-fold: (1) patients need information to prompt and help them to discuss family history with their unaffected FDRs, and (2) FDRs who are aware of a family history of PC should initiate discussions with their health care providers about whether or not they should be screened for PC, taking into account their individual risk factors, personal values, and preferences. Use of participatory approaches and involvement of patients and FDRs in this educational process was highly valued by the participants. Our decision aid includes the ''voices'' of patients speaking directly to other patients and FDRs to encourage dialogue and information sharing about PC diagnosis (family history) and experiences with this disease. The DVD also outlines both the potential immediate and downstream benefits and harms (pros and cons) that may result from either decision-to screen or not to screen. Thus, one of the goals of our decision aid was to deconstruct the controversy into easy-to-understand chunks of information (to improve comprehension) consistent with principles of low literacy education. [38] [39] [40] As examples, we broke down the IDM process using a four-step approach (data, discuss, deliberate, and decide), and illustrated the process through the lens and voices of patients, FDRs, and physicians. To further assess the utility of the decision aid, a quantitative evaluation is underway to test feasibility, impact, and outcomes in a randomized pilot study comparing the new enhanced decision aid (DVD) for FDRs vs. the CDC screening decision guides.
This was one of the first studies to assess the question of whether PC screening decision aids should be targeted by race/ethnicity. The argument for separate decision aids is fueled by the desire for racial-cultural tailoring of messages and dissemination channels. 24, 25 We did not find racial differences in perceptions and barriers to IDM; our data support the feasibility of a single decision aid For individual use only. Duplication or distribution prohibited by law.
targeted to both black and white FDRs. Thus, we developed one decision aid for both racial groups while attending to important surface structure cultural characteristics. The DVD purposely includes diversity with regard to both black/African-American and white patients, physicians and FDRs. Given the preliminary nature of our qualitative results, this question is being further assessed in a subsequent randomized pilot study with race/ethnicity as a stratification factor and two versions of the CDC decision guides. There continues to be a paucity of research in this area. Only one pilot study (n ¼ 22) of Australian men with a family history of PC reported positive evaluation of both a paper-based and an online interactive version of a screening decision aid 28 ; however, it is not clear whether the decision aid was developed specifically for FDRs. Further quantitative research is needed to evaluate the impact decision aids have on understanding screening controversy and skills for IDM among high-risk populations. Comparisons are also needed to assess whether the outcomes (of general decision aids vs. targeted decision aids for FDRs) differ in this high-risk population. Such comparative studies would contribute new knowledge to support or refute findings from studies with unaffected average-risk populations. 22, 41, 42 In that regard, this studywhich produced one of the first targeted decision aids for FDRs-takes the first step toward that goal.
Further research is needed to delineate practical and meaningful steps to study and communicate the harms and benefits of both IDM 43 and recommendations against PSA screening, 44 and to evaluate whether either perspective addresses the persistent disparities in PC outcomes. In addition, a reasonable question that could be proposed and rigorously tested in future studies is, ''Would a single PC screening decision aid for all men (with or without FDR status) be sufficient?'' Although this question is being investigated partially in a pilot randomized study underway among only FDRs comparing a general decision aid (non-FDR) to our enhanced decision aid (FDR status), a future study could stratify men by FDR status (with or without family history). This line of research is important and stems from (1) the current study finding that a single decision aid (not separated by race/ethnicity) was recommended by participants, (2) the national consensus recommendation to promote IDM for all men, and (3) practicalities of disseminating one product and potential efficiencies regarding widespread adoption and use of a single decision aid in multiple settings (doctor offices, benefit plans, worksite health promotion programs, community screenings, etc.).
The findings of this study should be considered in light of certain limitations. First, this is a qualitative study which involved purposive and convenience sampling, and a relatively small sample (N ¼ 44). Although this sample size is sufficient for general qualitative analyses, the study enrolled a limited number of men with lower socioeconomic status (including very low income or less than high school education), and was not intended to support rigorous quantitative statistical analyses. Furthermore, this sample size may not have been large enough to allow sufficient and exhaustive exploration of race-specific themes and preferences. As such, the question of ''tailoring'' by race needs to be further addressed in a future study. Overall, participants are not representative of the general population. For instance, the educational and income levels for both patients and FDRs were relatively high. Thus, it is possible that some patients with limited education, income, or health literacy would desire a race-''tailored'' decision aid. In addition, most FDRs had been screened previously for PC, and firmly held a proscreening or more favorable attitude toward screening. Inclusion of the perspectives of patients who chose active surveillance or those who had unfavorable treatment outcomes, or FDRs who chose not to be screened or had negative experiences with previous screening, may have produced different results. Despite these limitations, the article does have numerous strengths. This study used a qualitative approach, which allowed researchers to gain rich insights into the needs of patients and their FDRs. This was also the first study to address the unique IDM needs of unaffected male FDRs through the production of an FDRtargeted decision aid.
To the best of our knowledge, this is the first study to examine patients and their adult male FDRs' perceptions of PC screening controversy and IDM processes in the context of the development of a decision aid for FDRs. The perspectives of patients and FDRs guided development of a decision aid that deconstructs the IDM message and screening controversy into simpler sa-
SO WHAT? Implications for Health Promotion Practitioners and Researchers
What is already known on this topic?
There is considerable literature on IDM in cancer screening, including PC. [15] [16] [17] [18] [19] However, most of the literature does not separate findings or outcomes by FDR status. Furthermore, this is to our knowledge the first study to include perspectives of both patients and FDRs, and to integrate these perspectives into the development of a decision aid targeted specifically toward FDRs. The results of this study identify challenges in men's understanding and acceptance of the logic and basis for IDM recommendations.
What does this article add?
To our knowledge, this the first study in the United States to address the IDM needs of FDRs and to produce a decision aid targeted specifically toward them. This is also one of the first studies to assess whether PC screening decision aids should be separated by race/ethnicity. This study concluded that a single integrated decision aid suffices, but acknowledges this question should be further assessed in future larger randomized control trials. What are the implications for health promotion practice or research?
Until the decision aid is tested for feasibility and efficacy, the primary message for practitioners and researchers is to attend to the informational needs of each man-being cognizant that the screening controversy and IDM may not be intuitively meaningful to FDRs. Some men may require detailed dialogue to address why IDM is important, even for FDRs. The use of supplemental educational tools (decision aids) may help to further enrich these important discussions.
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lient messages, provides step-by-step strategies for participating in IDM, and encourages information sharing within the patient/FDR family unit-features that are often lacking in existing decision aids. 15, 16, 22 The findings from this study also led to the development of a single decision aid as recommended by study participants (PC patients and FDRs) regardless of race.
